Stacy Ku
Stock Analyst at TD Cowen
(0.90)
# 4,029
Out of 5,030 analysts
5
Total ratings
60%
Success rate
-11.16%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Stacy Ku
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals | Reinstates: Buy | $30 | $6.63 | +352.49% | 1 | Oct 15, 2025 | |
| CNTA Centessa Pharmaceuticals | Initiates: Buy | n/a | $23.02 | - | 1 | Jan 7, 2025 | |
| KALV KalVista Pharmaceuticals | Initiates: Buy | $30 | $11.10 | +170.27% | 1 | Jan 7, 2025 | |
| VRCA Verrica Pharmaceuticals | Maintains: Buy | $150 → $100 | $4.15 | +2,309.64% | 1 | Oct 21, 2024 | |
| ATXS Astria Therapeutics | Initiates: Buy | $35 | $11.98 | +192.15% | 1 | Jul 29, 2024 |
BioCryst Pharmaceuticals
Oct 15, 2025
Reinstates: Buy
Price Target: $30
Current: $6.63
Upside: +352.49%
Centessa Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: n/a
Current: $23.02
Upside: -
KalVista Pharmaceuticals
Jan 7, 2025
Initiates: Buy
Price Target: $30
Current: $11.10
Upside: +170.27%
Verrica Pharmaceuticals
Oct 21, 2024
Maintains: Buy
Price Target: $150 → $100
Current: $4.15
Upside: +2,309.64%
Astria Therapeutics
Jul 29, 2024
Initiates: Buy
Price Target: $35
Current: $11.98
Upside: +192.15%